Skip to content
Screener

Biohaven BHVN Total Current Liabilities

Total Current Liabilities at other companies

Eli Lilly logo
Eli LillyLLY
$47.74B+22.4%
Xenon Pharmaceuticals logo
Xenon PharmaceuticalsXENE
$45.01M+36.2%
Rapport Therapeutics, Inc. logo
Rapport Therapeutics, Inc.RAPP
$28.42M+139%
Vir Biotechnology, Inc. logo
Vir Biotechnology, Inc.VIR
$94.96M-9.6%
Monte Rosa Therapeutics, Inc. logo
Monte Rosa Therapeutics, Inc.GLUE
$59.66M+42.5%
Avalo Therapeutics logo
Avalo TherapeuticsAVTX
$21.13M+128%

Other financials

Income statement

See full
Operating income-$130.4M+41.1%
Net income-$130.5M+41.1%
EPS (diluted)-$0.88+59.4%

Balance sheet

See full
Cash & equivalents$277.1M+170%
Total debt$286.2M+706%
Total equity$129.5M-50.1%
Total assets$466.4M+1.6%

Cash flow

See full
Operating cash flow-$149.9M+9.2%
CapEx--100%
Free cash flow-$149.9M+9.5%

Valuation

See full
Market cap$2.17B+41.2%
Enterprise value$2.18B+31.3%

Returns & leverage

See full
Return on equity-333%+17.9pp
Debt / equity2.2×+2.1×
Current ratio7.4×+5.1×

Where this comes from

Reported directly by Biohaven in its filing.

Tagged under the XBRL concept us-gaap:LiabilitiesCurrent.

The source filing: Biohaven’s 10-Q, filed May 4, 2026.

Filed
May 4, 2026, 4:07 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001935979-26-000045
Line itemMarch 31, 2026December 31, 2025
Current liabilities:
Accounts payable$10,422$11,643
Accrued expenses and other current liabilities41,653104,291
Total current liabilities52,075115,934
Non-current operating lease liability38,36339,958
Notes payable241,912238,900
Other non-current liabilities4,5564,583
Total liabilities336,906399,375

Item 1. Unaudited Condensed Consolidated Financial Statements

FAQ

What is Biohaven's total current liabilities?
Biohaven (BHVN) reported total current liabilities of $52.08M in Q1 2026.
How has Biohaven's total current liabilities changed year-over-year?
Biohaven's total current liabilities decreased by 68.3% year-over-year, from $164.03M to $52.08M.
What is the long-term trend for Biohaven's total current liabilities?
Over 4 years (2021 to 2025), Biohaven's total current liabilities has grown at a 28.9% compound annual growth rate (CAGR), from $41.94M to $115.93M.
What does total current liabilities mean?
The sum of all obligations due within one year — payables, accrued expenses, current debt, deferred revenue, and other short-term liabilities.

Ask your AI about Biohaven's total current liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude